News and Trends 13 Dec 2017
CRISPR Therapeutics Plans First CRISPR/Cas9 Clinical Trial in Europe for 2018
…the first genome editing treatment of up to six that Vertex is entitled to license as per the agreement it signed with CRISPR Therapeutics back in 2015. CTX001 is what…